An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript

Jack T. Rogers, Jeffrey D. Randall, Catherine M. Cahill, Paul S. Eder, Xudong Huang, Hiromi Gunshin, Lorene Leiter, Jay McPhee, Satinder S. Sarang, Tada Utsuki, Nigel H. Greig, Debomoy Lahiri, Rudolph E. Tanzi, Ashley I. Bush, Tony Giordano, Steve R. Gullans

Research output: Contribution to journalArticle

383 Citations (Scopus)

Abstract

Iron-responsive elements (IREs) are the RNA stem loops that control cellular iron homeostasis by regulating ferritin translation and transferrin receptor mRNA stability. We mapped a novel iron-responsive element (IRE-Type II) within the 5′-untranslated region (5′-UTR) of the Alzheimer's amyloid precursor protein (APP) transcript (+51 to +94 from the 5′-cap site). The APP mRNA IRE is located immediately upstream of an interleukin-1 responsive acute box domain (+101 to +146). APP 5′-UTR conferred translation was selectively down-regulated in response to intracellular iron chelation using three separate reporter assays (chloramphenicol acetyltransferase, luciferase, and red fluorescent protein reflecting an inhibition of APP holoprotein translation in response to iron chelation. Iron influx reversed this inhibition. As an internal control to ensure specificity, a viral internal ribosome entry sequence was unresponsive to intracellular iron chelation with desferrioxamine. Using RNA mobility shift assays, the APP 5′-UTRs, encompassing the IRE, bind specifically to recombinant iron-regulatory proteins (IRP) and to IRP from neuroblastoma cell lysates. IRP binding to the APP 5′-UTR is reduced after treatment of cells with desferrioxamine and increased after interleukin-1 stimulation. IRP binding is abrogated when APP cRNA probe is mutated in the core IRE domain (A4 bases:A83AGAG86). Iron regulation of APP mRNA through the APP 5′-UTR points to a role for iron in the metabolism of APP and confirms that this RNA structure can be a target for the selection of small molecule drugs, such as desferrioxamine (Fe chelator) and clioquinol (Fe, Cu, and Zn chelator), which reduce Aβ peptide burden during Alzheimer's disease.

Original languageEnglish
Pages (from-to)45518-45528
Number of pages11
JournalJournal of Biological Chemistry
Volume277
Issue number47
DOIs
StatePublished - Nov 22 2002

Fingerprint

Amyloid beta-Protein Precursor
5' Untranslated Regions
Iron
Iron-Regulatory Proteins
Deferoxamine
Chelation
RNA
Chelating Agents
Interleukin-1
Protein Binding
Messenger RNA
Assays
Clioquinol
Complementary RNA
Chloramphenicol O-Acetyltransferase
Transferrin Receptors
RNA Stability
Protein Biosynthesis
Electrophoretic Mobility Shift Assay
Ferritins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., ... Gullans, S. R. (2002). An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. Journal of Biological Chemistry, 277(47), 45518-45528. https://doi.org/10.1074/jbc.M207435200

An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. / Rogers, Jack T.; Randall, Jeffrey D.; Cahill, Catherine M.; Eder, Paul S.; Huang, Xudong; Gunshin, Hiromi; Leiter, Lorene; McPhee, Jay; Sarang, Satinder S.; Utsuki, Tada; Greig, Nigel H.; Lahiri, Debomoy; Tanzi, Rudolph E.; Bush, Ashley I.; Giordano, Tony; Gullans, Steve R.

In: Journal of Biological Chemistry, Vol. 277, No. 47, 22.11.2002, p. 45518-45528.

Research output: Contribution to journalArticle

Rogers, JT, Randall, JD, Cahill, CM, Eder, PS, Huang, X, Gunshin, H, Leiter, L, McPhee, J, Sarang, SS, Utsuki, T, Greig, NH, Lahiri, D, Tanzi, RE, Bush, AI, Giordano, T & Gullans, SR 2002, 'An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript', Journal of Biological Chemistry, vol. 277, no. 47, pp. 45518-45528. https://doi.org/10.1074/jbc.M207435200
Rogers, Jack T. ; Randall, Jeffrey D. ; Cahill, Catherine M. ; Eder, Paul S. ; Huang, Xudong ; Gunshin, Hiromi ; Leiter, Lorene ; McPhee, Jay ; Sarang, Satinder S. ; Utsuki, Tada ; Greig, Nigel H. ; Lahiri, Debomoy ; Tanzi, Rudolph E. ; Bush, Ashley I. ; Giordano, Tony ; Gullans, Steve R. / An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 47. pp. 45518-45528.
@article{2037aad96da44757910667d796a40cfa,
title = "An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript",
abstract = "Iron-responsive elements (IREs) are the RNA stem loops that control cellular iron homeostasis by regulating ferritin translation and transferrin receptor mRNA stability. We mapped a novel iron-responsive element (IRE-Type II) within the 5′-untranslated region (5′-UTR) of the Alzheimer's amyloid precursor protein (APP) transcript (+51 to +94 from the 5′-cap site). The APP mRNA IRE is located immediately upstream of an interleukin-1 responsive acute box domain (+101 to +146). APP 5′-UTR conferred translation was selectively down-regulated in response to intracellular iron chelation using three separate reporter assays (chloramphenicol acetyltransferase, luciferase, and red fluorescent protein reflecting an inhibition of APP holoprotein translation in response to iron chelation. Iron influx reversed this inhibition. As an internal control to ensure specificity, a viral internal ribosome entry sequence was unresponsive to intracellular iron chelation with desferrioxamine. Using RNA mobility shift assays, the APP 5′-UTRs, encompassing the IRE, bind specifically to recombinant iron-regulatory proteins (IRP) and to IRP from neuroblastoma cell lysates. IRP binding to the APP 5′-UTR is reduced after treatment of cells with desferrioxamine and increased after interleukin-1 stimulation. IRP binding is abrogated when APP cRNA probe is mutated in the core IRE domain (A4 bases:A83AGAG86). Iron regulation of APP mRNA through the APP 5′-UTR points to a role for iron in the metabolism of APP and confirms that this RNA structure can be a target for the selection of small molecule drugs, such as desferrioxamine (Fe chelator) and clioquinol (Fe, Cu, and Zn chelator), which reduce Aβ peptide burden during Alzheimer's disease.",
author = "Rogers, {Jack T.} and Randall, {Jeffrey D.} and Cahill, {Catherine M.} and Eder, {Paul S.} and Xudong Huang and Hiromi Gunshin and Lorene Leiter and Jay McPhee and Sarang, {Satinder S.} and Tada Utsuki and Greig, {Nigel H.} and Debomoy Lahiri and Tanzi, {Rudolph E.} and Bush, {Ashley I.} and Tony Giordano and Gullans, {Steve R.}",
year = "2002",
month = "11",
day = "22",
doi = "10.1074/jbc.M207435200",
language = "English",
volume = "277",
pages = "45518--45528",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "47",

}

TY - JOUR

T1 - An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript

AU - Rogers, Jack T.

AU - Randall, Jeffrey D.

AU - Cahill, Catherine M.

AU - Eder, Paul S.

AU - Huang, Xudong

AU - Gunshin, Hiromi

AU - Leiter, Lorene

AU - McPhee, Jay

AU - Sarang, Satinder S.

AU - Utsuki, Tada

AU - Greig, Nigel H.

AU - Lahiri, Debomoy

AU - Tanzi, Rudolph E.

AU - Bush, Ashley I.

AU - Giordano, Tony

AU - Gullans, Steve R.

PY - 2002/11/22

Y1 - 2002/11/22

N2 - Iron-responsive elements (IREs) are the RNA stem loops that control cellular iron homeostasis by regulating ferritin translation and transferrin receptor mRNA stability. We mapped a novel iron-responsive element (IRE-Type II) within the 5′-untranslated region (5′-UTR) of the Alzheimer's amyloid precursor protein (APP) transcript (+51 to +94 from the 5′-cap site). The APP mRNA IRE is located immediately upstream of an interleukin-1 responsive acute box domain (+101 to +146). APP 5′-UTR conferred translation was selectively down-regulated in response to intracellular iron chelation using three separate reporter assays (chloramphenicol acetyltransferase, luciferase, and red fluorescent protein reflecting an inhibition of APP holoprotein translation in response to iron chelation. Iron influx reversed this inhibition. As an internal control to ensure specificity, a viral internal ribosome entry sequence was unresponsive to intracellular iron chelation with desferrioxamine. Using RNA mobility shift assays, the APP 5′-UTRs, encompassing the IRE, bind specifically to recombinant iron-regulatory proteins (IRP) and to IRP from neuroblastoma cell lysates. IRP binding to the APP 5′-UTR is reduced after treatment of cells with desferrioxamine and increased after interleukin-1 stimulation. IRP binding is abrogated when APP cRNA probe is mutated in the core IRE domain (A4 bases:A83AGAG86). Iron regulation of APP mRNA through the APP 5′-UTR points to a role for iron in the metabolism of APP and confirms that this RNA structure can be a target for the selection of small molecule drugs, such as desferrioxamine (Fe chelator) and clioquinol (Fe, Cu, and Zn chelator), which reduce Aβ peptide burden during Alzheimer's disease.

AB - Iron-responsive elements (IREs) are the RNA stem loops that control cellular iron homeostasis by regulating ferritin translation and transferrin receptor mRNA stability. We mapped a novel iron-responsive element (IRE-Type II) within the 5′-untranslated region (5′-UTR) of the Alzheimer's amyloid precursor protein (APP) transcript (+51 to +94 from the 5′-cap site). The APP mRNA IRE is located immediately upstream of an interleukin-1 responsive acute box domain (+101 to +146). APP 5′-UTR conferred translation was selectively down-regulated in response to intracellular iron chelation using three separate reporter assays (chloramphenicol acetyltransferase, luciferase, and red fluorescent protein reflecting an inhibition of APP holoprotein translation in response to iron chelation. Iron influx reversed this inhibition. As an internal control to ensure specificity, a viral internal ribosome entry sequence was unresponsive to intracellular iron chelation with desferrioxamine. Using RNA mobility shift assays, the APP 5′-UTRs, encompassing the IRE, bind specifically to recombinant iron-regulatory proteins (IRP) and to IRP from neuroblastoma cell lysates. IRP binding to the APP 5′-UTR is reduced after treatment of cells with desferrioxamine and increased after interleukin-1 stimulation. IRP binding is abrogated when APP cRNA probe is mutated in the core IRE domain (A4 bases:A83AGAG86). Iron regulation of APP mRNA through the APP 5′-UTR points to a role for iron in the metabolism of APP and confirms that this RNA structure can be a target for the selection of small molecule drugs, such as desferrioxamine (Fe chelator) and clioquinol (Fe, Cu, and Zn chelator), which reduce Aβ peptide burden during Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0347928847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347928847&partnerID=8YFLogxK

U2 - 10.1074/jbc.M207435200

DO - 10.1074/jbc.M207435200

M3 - Article

VL - 277

SP - 45518

EP - 45528

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 47

ER -